These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32579748)

  • 1. Psychosocial factors associated with HbA
    Schmidt S; Andersen Nexø M; Norgaard O; Willaing I; Pedersen-Bjergaard U; Skinner TC; Nørgaard K
    Diabet Med; 2020 Sep; 37(9):1454-1462. PubMed ID: 32579748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
    Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
    Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
    Boland EA; Grey M; Oesterle A; Fredrickson L; Tamborlane WV
    Diabetes Care; 1999 Nov; 22(11):1779-84. PubMed ID: 10546007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life.
    McMahon SK; Airey FL; Marangou DA; McElwee KJ; Carne CL; Clarey AJ; Davis EA; Jones TW
    Diabet Med; 2005 Jan; 22(1):92-6. PubMed ID: 15606698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes.
    Kallas-Koeman MM; Kong JM; Klinke JA; Butalia S; Lodha AK; Lim KI; Duan QM; Donovan LE
    Diabetologia; 2014 Apr; 57(4):681-9. PubMed ID: 24434960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the effectiveness of long-term insulin pump therapy using a combined goal of HbA
    Quirós C; Viñals C; Giménez M; Roca D; Conget I
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Nov; 66(9):534-539. PubMed ID: 31133475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control?
    Nixon R; Pickup JC
    Diabetes Technol Ther; 2011 Feb; 13(2):93-8. PubMed ID: 21284474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring factors influencing HbA1c and psychosocial outcomes in people with type 1 diabetes after training in advanced carbohydrate counting.
    Schmidt S; Vistisen D; Almdal T; Hommel E; Nørgaard K
    Diabetes Res Clin Pract; 2017 Aug; 130():61-66. PubMed ID: 28570925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of anxiety and depression on patients within a large type 1 diabetes insulin pump population. An observational study.
    Grant P; Dworakowska D; DeZoysa N; Barnes D
    Diabetes Metab; 2013 Oct; 39(5):439-44. PubMed ID: 24076359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coping strategies in people with type 1 diabetes on insulin pump treatment.
    Bisio A; Gamarra E; Broglio F; Grassi G
    Minerva Endocrinol; 2019 Dec; 44(4):336-343. PubMed ID: 31240899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOCTURNAL HYPOGLYCEMIA--THE MAIN INDICATION FOR INSULIN PUMP THERAPY IN ADULTHOOD.
    Baretić M; Kraljević I; Renar IP
    Acta Clin Croat; 2016 Mar; 55(1):93-9. PubMed ID: 27333724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin pump treatment in children and adolescents with type 1 diabetes.
    Hofer S; Meraner D; Koehle J
    Minerva Pediatr; 2012 Aug; 64(4):433-8. PubMed ID: 22728614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.
    Hermanides J; Nørgaard K; Bruttomesso D; Mathieu C; Frid A; Dayan CM; Diem P; Fermon C; Wentholt IM; Hoekstra JB; DeVries JH
    Diabet Med; 2011 Oct; 28(10):1158-67. PubMed ID: 21294770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study.
    Charleer S; De Block C; Nobels F; Radermecker RP; Lowyck I; Mullens A; Scarnière D; Spincemaille K; Strivay M; Weber E; Taes Y; Vercammen C; Keymeulen B; Mathieu C; Gillard P;
    Diabetes Care; 2020 Dec; 43(12):3016-3023. PubMed ID: 33067260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of DAFNE education, continuous subcutaneous insulin infusion, or both in a population with type 1 diabetes in Scotland.
    McKnight JA; Ochs A; Mair C; McKnight O; Wright R; Gibb FW; Cunningham SG; Strachan M; Ritchie S; McGurnaghan SJ; Colhoun HM
    Diabet Med; 2020 Jun; 37(6):1016-1022. PubMed ID: 31872473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six months of hybrid closed loop in the real-world: An evaluation of children and young adults using the 670G system.
    Berget C; Messer LH; Vigers T; Frohnert BI; Pyle L; Wadwa RP; Driscoll KA; Forlenza GP
    Pediatr Diabetes; 2020 Mar; 21(2):310-318. PubMed ID: 31837064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol.
    Bally L; Thabit H; Tauschmann M; Allen JM; Hartnell S; Wilinska ME; Exall J; Huegel V; Sibayan J; Borgman S; Cheng P; Blackburn M; Lawton J; Elleri D; Leelarathna L; Acerini CL; Campbell F; Shah VN; Criego A; Evans ML; Dunger DB; Kollman C; Bergenstal RM; Hovorka R
    BMJ Open; 2017 Jul; 7(7):e016738. PubMed ID: 28710224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of factors associated with glycaemic control in adults with Type 1 diabetes mellitus on insulin pump therapy.
    Wen W; Frampton R; Wright K; Fattore S; Shadbolt B; Perampalam S
    Diabet Med; 2016 Feb; 33(2):231-4. PubMed ID: 26484625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.